🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/09/2006 20,34 21,36 20,34 21,30 +4,72% 5,01% 111.817
11/09/2006 21,06 21,06 20,10 20,34 -4,24% 4,56% 71.650
08/09/2006 21,60 21,78 20,28 21,24 -2,21% 6,94% 99.183
07/09/2006 22,38 22,50 21,30 21,72 -3,21% 5,36% 97.450
06/09/2006 23,88 24,00 22,32 22,44 -6,03% 7,04% 105.300
05/09/2006 24,00 24,84 23,58 23,88 -3,86% 5,25% 114.067
01/09/2006 24,90 25,08 24,30 24,84 +0,24% 3,13% 36.567
31/08/2006 25,20 25,38 24,60 24,78 -0,24% 3,10% 84.800
30/08/2006 24,00 25,56 23,52 24,84 +3,76% 8,50% 134.633
29/08/2006 23,70 24,06 22,86 23,94 +0,50% 5,06% 57.533
28/08/2006 23,70 24,24 23,58 23,82 +0,51% 2,78% 67.083
25/08/2006 23,22 24,30 22,80 23,70 +2,60% 6,46% 86.183
24/08/2006 23,22 24,12 22,56 23,10 +0,26% 6,72% 99.883
23/08/2006 25,50 26,10 22,86 23,04 -10,28% 12,71% 284.917
22/08/2006 21,66 26,88 21,30 25,68 +19,55% 25,76% 774.333
21/08/2006 20,10 22,26 19,62 21,48 +8,48% 13,13% 248.583
18/08/2006 18,00 21,18 17,94 19,80 +10,37% 18,00% 177.833
17/08/2006 17,40 18,06 17,16 17,94 +4,55% 5,17% 51.200
16/08/2006 16,62 17,52 16,62 17,16 +3,62% 5,42% 65.183
15/08/2006 16,74 16,74 16,32 16,56 +0,36% 2,51% 45.350
14/08/2006 16,20 17,28 16,20 16,50 +2,23% 6,67% 47.017
11/08/2006 16,20 16,44 15,90 16,14 -1,10% 3,33% 32.800
10/08/2006 16,08 16,92 15,96 16,32 +0,74% 5,97% 70.233
09/08/2006 17,16 17,82 16,08 16,20 +0,37% 10,14% 116.533
08/08/2006 17,58 17,82 16,08 16,14 -9,12% 9,90% 97.183
07/08/2006 18,42 18,48 17,34 17,76 -4,52% 6,19% 87.533
04/08/2006 19,44 19,62 18,00 18,60 -0,96% 8,33% 65.000
03/08/2006 18,48 18,84 17,82 18,78 +6,10% 5,52% 64.733
02/08/2006 18,72 19,98 17,70 17,70 -5,14% 12,18% 139.167
01/08/2006 17,34 20,22 16,74 18,66 +9,89% 20,07% 239.767